OTCMKTS:SCIE - SpectraScience Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0001 0.00 (0.00 %)
(As of 01/23/2019 07:12 AM ET)
Previous Close$0.0001
Today's Range$0.0001 - $0.0001
52-Week Range$0.0001 - $0.0002
Volume17.00 million shs
Average Volume33.53 million shs
Market Capitalization$492,379.00
P/E RatioN/A
Dividend YieldN/A
SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.

Receive SCIE News and Ratings via Email

Sign-up to receive the latest news and ratings for SCIE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Current SymbolOTCMKTS:SCIE



Sales & Book Value

Annual SalesN/A



Outstanding Shares4,923,790,000
Market Cap$492,379.00
OptionableNot Optionable

SpectraScience (OTCMKTS:SCIE) Frequently Asked Questions

What is SpectraScience's stock symbol?

SpectraScience trades on the OTCMKTS under the ticker symbol "SCIE."

When is SpectraScience's next earnings date?

SpectraScience is scheduled to release their next quarterly earnings announcement on Wednesday, February 13th 2019. View Earnings Estimates for SpectraScience.

Has SpectraScience been receiving favorable news coverage?

Headlines about SCIE stock have trended positive recently, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. SpectraScience earned a coverage optimism score of 2.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the company's share price in the next several days.

Who are some of SpectraScience's key competitors?

Who are SpectraScience's key executives?

SpectraScience's management team includes the folowing people:
  • Mr. Michael P. Oliver, CEO, Pres, COO & Director (Age 71)
  • Mr. Lowell W. Giffhorn, CFO & Sec. (Age 72)
  • Mr. Charles Negus, Director of Operations - LUMA(TM)
  • Mr. Michael Brady, Director of Engineering
  • Mr. Hughes Wielemans, Director of Bus. Devel. - Europe

How do I buy shares of SpectraScience?

Shares of SCIE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SpectraScience's stock price today?

One share of SCIE stock can currently be purchased for approximately $0.0001.

How big of a company is SpectraScience?

SpectraScience has a market capitalization of $492,379.00.

What is SpectraScience's official website?

The official website for SpectraScience is http://www.spectrascience.com.

How can I contact SpectraScience?

SpectraScience's mailing address is 11568 SORRENTO VALLEY ROAD SUITE 11, SAN DIEGO CA, 92121. The company can be reached via phone at 858-847-0200.

MarketBeat Community Rating for SpectraScience (OTCMKTS SCIE)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  65
MarketBeat's community ratings are surveys of what our community members think about SpectraScience and other stocks. Vote "Outperform" if you believe SCIE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SCIE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel